Listar por tema "acute coronary syndrome"

Analysis of the quality of reporting of randomized controlled trials in anticoagulant versus antiplatelet medication for venous thromboembolism prophylaxis as governed by the CONSORT statement

Beneki E., Vrysis C., Zintzaras E., Doxani C. (2021)

Randomized controlled trials (RCTs) are the gold standard research in evaluating healthcare interventions. The CONSORT (Consolidated Standards of Reporting Trials) statement improves the quality of RCTs in an evidence-based ...

Antithrombotic therapy for elderly patients with acute coronary syndrome: Reasons to be cautious

Kotsiou O.S., Xirogiannis I.K. (2020)

[No abstract available]

Are patients with covid-19 dying of or with cardiac injury?

Tsolaki V., Zakynthinos G.E. (2020)

[No abstract available]

Cardiac telerehabilitation improves lipid profile in the long term: Insights and implications

Batalik L., Pepera G., Su J.J. (2022)

[No abstract available]

Comparative Performance of Three Metabolic Syndrome Definitions in the Prediction of Acute Coronary Syndrome

Koutsovasilis, A.; Protopsaltis, J.; Triposkiadis, F.; Kokkoris, S.; Milionis, H. J.; Zairis, M. N.; Skoularigis, J.; Koukoulis, G.; Korantzopoulos, P.; Melidonis, A.; Foussas, S. G. (2009)

Objective The value of the recently introduced definitions of metabolic syndrome (MetS) in the identification of high cardiovascular risk subjects remains questionable. We examined the association among different definitions ...

COVID-19 and the cardiovascular system-current knowledge and future perspectives

Chatzis D.G., Magounaki K., Pantazopoulos I., Bhaskar S.M.M. (2022)

The current coronavirus disease 2019 (COVID-19) pandemic has had devastating impact on populations around the world. The high mortality rates in patients with COVID-19 has been attributed to the influence of severe acute ...

COVID-19 pandemic and cardiovascular disease: where do we stand?

Chatzis D.G., Magounaki K.T., Pantazopoulos I.N., Johnson E.O., Tsioufis K.P. (2020)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of coronavirus disease 2019 (COVID-19) which recently has been characterized as a pandemic by the World Health Organization (WHO) having killed ...

The effect of in-hospital acquired thrombocytopenia on the outcome of patients with acute coronary syndromes: A systematic review and meta-analysis

Oikonomou E.K., Repanas T.I., Papanastasiou C., Kokkinidis D.G., Miligkos M., Feher A., Gupta D., Kampaktsis P.N. (2016)

Background In-hospital acquired thrombocytopenia (TP) is relatively common among patients hospitalized with acute coronary syndromes (ACS). However, its effect on short-term and long-term outcomes has yet to be reviewed ...

Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review

Pepera G., Tribali M.-S., Batalik L., Petrov I., Papathanasiou J. (2022)

Background: Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from China, the novel coronavirus disease 2019 (COVID-19) has caused more than five milion deaths worldwide. Several studies ...

The management of atrial fibrillation in heart failure: an expert panel consensus

Farmakis D., Chrysohoou C., Giamouzis G., Giannakoulas G., Hamilos M., Naka K., Tzeis S., Xydonas S., Karavidas A., Parissis J. (2021)

Heart failure (HF) and atrial fibrillation (AF) often coexist, being closely interrelated as the one increases the prevalence and incidence and worsens the prognosis of the other. Their frequent coexistence raises several ...

Novel Clinical Concepts in Thrombosis: Integrated Care for Stroke Management-Easy as ABC

Lip G.Y.H., Ntaios G. (2022)

[No abstract available]

Premature CAD: Conventional Screening and Diagnostic Strategies May Not Capture the “Whole Picture”

Angelidis G., Valotassiou V., Satra M., Psimadas D., Georgoulias P. (2021)

[No abstract available]

Proprotein Convertase Subtilisin-Kexin Type 9 inhibitors and stroke prevention: A meta-analysis

Sagris D., Ntaios G., Georgiopoulos G., Pateras K., Milionis H. (2021)

[No abstract available]

Red blood cell distribution width in elderly hospitalized patients with cardiovascular disease

Xanthopoulos A., Tryposkiadis K., Dimos A., Bourazana A., Zagouras A., Iakovis N., Papamichalis M., Giamouzis G., Vassilopoulos G., Skoularigis J., Triposkiadis F. (2021)

BACKGROUND Red blood cell distribution width (RDW) is elevated in patients with cardiovascular disease (CVD). AIM To determine RDW values and impact of CV and non-CV coexisting morbidities in elderly patients hospitalized ...

Reinforcing adherence to lipid-lowering therapy after an acute coronary syndrome: A pragmatic randomized controlled trial

Zafeiropoulos S., Farmakis I., Kartas A., Arvanitaki A., Pagiantza A., Boulmpou A., Tampaki A., Kosmidis D., Nevras V., Markidis E., Papadimitriou I., Vlachou A., Arvanitakis K., Miyara S.J., Ziakas A., Molmenti E.P., Kassimis G., Zanos S., Karvounis H., Giannakoulas G. (2021)

Background and aims: Achieving the low-density lipoprotein cholesterol (LDL-C) goal following an acute coronary syndrome (ACS) is a milestone often missed due to suboptimal adherence to secondary prevention treatments. ...

Renin-angiotensin-system inhibition in the context of corona virus disease-19: experimental evidence, observational studies, and clinical implications

Triposkiadis F., Starling R.C., Xanthopoulos A., Butler J., Boudoulas H. (2021)

Coronavirus disease 2019 (COVID-19) is due to severe acute respiratory syndrome coronavirus (SARS-CoV)-2 which binds and enters the host cells through the angiotensin-converting enzyme (ACE)2. While the potential for benefit ...

Risk for Recurrent Cardiovascular Events and Expected Risk Reduction With Optimal Treatment 1 Year After an Acute Coronary Syndrome

Zafeiropoulos S., Farmakis I., Kartas A., Arvanitaki A., Pagiantza A., Boulmpou A., Tampaki A., Kosmidis D., Nevras V., Markidis E., Papadimitriou I., Arvanitakis K., Sianos G., Makedou K., Ziakas A., Tzikas A., Karvounis H., Giannakoulas G. (2020)

According to the latest European Society of Cardiology Guidelines for the diagnosis and management of chronic coronary syndromes, patients who suffered an acute coronary syndrome fall into a chronic stable phase after 1 ...